Protalix BioTherapeutics, Inc. (PLX) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Revenue from Selling Goods | 7.42M | FY2026-Q1 |
| Cash and Cash Runway | 51.1M | FY2026-Q1 |
Back to PLX overview · PLX earnings · PLX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.